BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

PLXP: Band Back Together, Initiating with Buy

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul>
<li>The third quarter was the first time PLx Pharma (PLXP) reported net sales of VAZALORE and they were above our forecast</li>
<li>PLXP had stayed quiet to the extent of the sales it would generate until the quarterly results were released. </li>
<li>Retailers stocked up ahead of the holidays and would clear out their current stock before making new purchases in January</li>
</ul>


The third quarter was the first time PLx Pharma (PLXP) reported net sales of VAZALORE and they were above our forecast
PLXP had stayed quiet to the extent of the sales it would generate until the quarterly results were released. 
Retailers stocked up ahead of the holidays and would clear out their current stock before making new purchases in January


PLx Pharma

PLXP: Investing in Growth